PLATINUM Diversity: Outcomes With the Promus PREMIER Stent in Women and Minorities (S2326)
Phase of Trial: Phase IV
Latest Information Update: 19 May 2017
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms PLATINUM Diversity
- Sponsors Boston Scientific Corporation
- 19 May 2017 According to a Boston Scientific Corporation media release, New data from this study was presented at the 40th Annual Society for Cardiac Angiography and Interventions (SCAI) Scientific Sessions.
- 07 Mar 2017 Last checked against ClinicalTrials.gov record.
- 02 Mar 2017 Status changed from active, no longer recruiting to completed.